138 related articles for article (PubMed ID: 30520388)
1. miR-342-5p as a Potential Regulator of HER2 Breast Cancer Cell Growth.
Lindholm EM; Leivonen SK; Undlien E; Nebdal D; Git A; Caldas C; Børresen-Dale AL; Kleivi K
Microrna; 2019; 8(2):155-165. PubMed ID: 30520388
[TBL] [Abstract][Full Text] [Related]
2. High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth.
Leivonen SK; Sahlberg KK; Mäkelä R; Due EU; Kallioniemi O; Børresen-Dale AL; Perälä M
Mol Oncol; 2014 Feb; 8(1):93-104. PubMed ID: 24148764
[TBL] [Abstract][Full Text] [Related]
3. Functional SNP in stem of mir-146a affects Her2 status and breast cancer survival.
Meshkat M; Tanha HM; Naeini MM; Ghaedi K; Sanati MH; Meshkat M; Bagheri F
Cancer Biomark; 2016 Jul; 17(2):213-22. PubMed ID: 27434289
[TBL] [Abstract][Full Text] [Related]
4. MiR-4728-3p could act as a marker of HER2 status.
Li H; Zhou X; Zhu J; Cheng W; Zhu W; Shu Y; Liu P
Cancer Biomark; 2015; 15(6):807-14. PubMed ID: 26406406
[TBL] [Abstract][Full Text] [Related]
5. NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer.
Lund RR; Leth-Larsen R; Caterino TD; Terp MG; Nissen J; Lænkholm AV; Jensen ON; Ditzel HJ
Mol Cell Proteomics; 2015 Nov; 14(11):2988-99. PubMed ID: 26351264
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1.
Lv M; Mao Q; Li J; Qiao J; Chen X; Luo S
Cell Mol Biol Lett; 2020; 25():43. PubMed ID: 32983239
[TBL] [Abstract][Full Text] [Related]
7. MiR-18a-5p attenuates HER2-positive breast cancer development by regulating PI3K/AKT pathway.
Liu Y; Yang H
Cancer Biol Ther; 2023 Dec; 24(1):2224512. PubMed ID: 37394766
[TBL] [Abstract][Full Text] [Related]
8. Dynamically decreased miR-671-5p expression is associated with oncogenic transformation and radiochemoresistance in breast cancer.
Tan X; Li Z; Ren S; Rezaei K; Pan Q; Goldstein AT; Macri CJ; Cao D; Brem RF; Fu SW
Breast Cancer Res; 2019 Aug; 21(1):89. PubMed ID: 31391072
[TBL] [Abstract][Full Text] [Related]
9. HER2-intronic miR-4728-5p facilitates HER2 expression and accelerates cell proliferation and migration by targeting EBP1 in breast cancer.
Zhou Y; Yuan Y; Li L; Wang X; Quan Y; Liu C; Yu M; Hu X; Meng X; Zhou Z; Zhang CY; Chen X; Liu M; Wang C
PLoS One; 2021; 16(2):e0245832. PubMed ID: 33529238
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic potential of TSTA3 in breast cancer and its regulation by the tumor suppressors miR-125a-5p and miR-125b.
Sun Y; Liu X; Zhang Q; Mao X; Feng L; Su P; Chen H; Guo Y; Jin F
Tumour Biol; 2016 Apr; 37(4):4963-72. PubMed ID: 26531722
[TBL] [Abstract][Full Text] [Related]
11. PVT1-derived miR-1207-5p promotes breast cancer cell growth by targeting STAT6.
Yan C; Chen Y; Kong W; Fu L; Liu Y; Yao Q; Yuan Y
Cancer Sci; 2017 May; 108(5):868-876. PubMed ID: 28235236
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting Oncogenic HMGA2.
Mansoori B; Kiani S; Mezajin AA; Zandi P; Banaie H; Rostamzadeh D; Cho WC; Duijf PHG; Mansoori B; Baradaran B
Clin Breast Cancer; 2023 Oct; 23(7):e480-e490.e3. PubMed ID: 37596147
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.
Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X
Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245
[TBL] [Abstract][Full Text] [Related]
14. MiR-379-5p inhibits the proliferation, migration, and invasion of breast cancer by targeting KIF4A.
Yang K; Li D; Jia W; Song Y; Sun N; Wang J; Li H; Yin C
Thorac Cancer; 2022 Jul; 13(13):1916-1924. PubMed ID: 35608059
[TBL] [Abstract][Full Text] [Related]
15. MiR-199b-5p targets HER2 in breast cancer cells.
Fang C; Zhao Y; Guo B
J Cell Biochem; 2013 Jul; 114(7):1457-63. PubMed ID: 23296799
[TBL] [Abstract][Full Text] [Related]
16. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis.
Wu X; Kong C; Wu Y
Bioengineered; 2021 Dec; 12(1):9046-9057. PubMed ID: 34657558
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the Dysregulation of miR-23b-3p, miR-195-5p, miR-656-5p, and miR-340-5p in Trastuzumab Resistance of HER2-Positive Breast Cancer Cells and System Biology Approach to Predict Their Targets Involved in Resistance.
Rezaei Z; Sebzari A; Kordi-Tamandani DM; Dastjerdi K
DNA Cell Biol; 2019 Feb; 38(2):184-192. PubMed ID: 30702337
[TBL] [Abstract][Full Text] [Related]
18. Theranostic application of
Cava C; Novello C; Martelli C; Lodico A; Ottobrini L; Piccotti F; Truffi M; Corsi F; Bertoli G; Castiglioni I
Theranostics; 2020; 10(1):50-61. PubMed ID: 31903105
[TBL] [Abstract][Full Text] [Related]
19. Rac-specific guanine nucleotide exchange factor DOCK1 is a critical regulator of HER2-mediated breast cancer metastasis.
Laurin M; Huber J; Pelletier A; Houalla T; Park M; Fukui Y; Haibe-Kains B; Muller WJ; Côté JF
Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7434-9. PubMed ID: 23592719
[TBL] [Abstract][Full Text] [Related]
20. Alteration of miR-362-5p and miR-454-3p expression elicits diverse responses in breast cancer cell lines.
Aarthy R; Rao AKDM; Patel K; Sridevi V; Rajkumar T; Gowda H; Mani S
Mol Biol Rep; 2022 Jan; 49(1):821-826. PubMed ID: 34727290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
